Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01162564 · ClinicalTrials.gov registry record
Flexible Composite Next Generation Tissue Separating Mesh in Laparoscopic Incisional/Ventral Hernia Repair
A clinical trial of Ventral Hernia and Incisional Hernia, sponsored by Ethicon.
- Completed
- Registry status
- 48
- Enrollment target
- 6
- Study locations
NCT01162564 is a study of Ventral Hernia and Incisional Hernia that has completed, run by Ethicon. The registered enrollment target is 48 participants, below the 140-participant average among 18 other Ventral Hernia trials with a reported enrollment target (66% lower). The trial reports 6 study locations across 4 states.
The verdict
NCT01162564, a study of Ventral Hernia and Incisional Hernia, has completed, sponsored by Ethicon.
- COMPLETED
- Registry status
- 48 participants
- Enrollment target
- 6
- Study locations
Study Summary
This is a multi-center, observational study of incisional/ventral hernia repair with NG-TSM laparoscopically. The study is not randomized and has a single treatment design assessing NG-TSM intra-operatively, its ease of use and handling characteristics.
Conditions Studied
Interventions
- DEVICE NG-TSM
Study Locations (6)
Missouri
- Capital Region Hospital - Jefferson City
- Washington University School of Medicine / Dept of Surgery - St Louis
North Carolina
- First Health Moore Regional Hospital - Pinehurst
- New Hanover Regional Hospital - Wilmington
New York
- Montefiore Medical Center - The Bronx
Virginia
- Eastern Virginia Medical School - Norfolk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2010-06 |
| Est. Completion | 2011-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01162564
The ClinicalTrials.gov registry entry for NCT01162564 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 140-participant average among 18 other Ventral Hernia trials with a reported enrollment target (66% lower). The listed sponsor is Ethicon, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Ventral Hernia appearing as the primary indexed condition, and to 1 intervention - of which NG-TSM is the first listed.
NCT01162564 reports 6 study locations spanning 4 distinct geographic areas - top geographies include Missouri, North Carolina, New York.
Frequently Asked Questions
What is clinical trial NCT01162564 about?
NCT01162564 is a clinical study titled "Flexible Composite Next Generation Tissue Separating Mesh in Laparoscopic Incisional/Ventral Hernia Repair". This is a multi-center, observational study of incisional/ventral hernia repair with NG-TSM laparoscopically. The study is not randomized and has a single treatment design assessing NG-TSM intra-operatively, its ease of use and handling characteristics.
What is the current status of trial NCT01162564?
This trial is currently completed. The enrollment target is 48 participants. The study started on 2010-06. Estimated completion is 2011-01.
What conditions does trial NCT01162564 study?
This clinical trial studies the following conditions: Ventral Hernia, Incisional Hernia.
What interventions are being tested in trial NCT01162564?
The interventions under investigation include: NG-TSM (DEVICE).
Who is sponsoring clinical trial NCT01162564?
This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01162564 being conducted?
This trial has 6 study locations across Missouri, New York, North Carolina, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventral Hernia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
AFFIX: Post-market Study of MaxTack™ Motorized Fixation Device in Subjects Undergoing Ventral Hernia Repair
RECRUITING · NA
-
Robotic Versus Open Ventral Hernia Repair
RECRUITING · NA
-
Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants Undergoing Open Abdominal Ventral Hernia Repair
RECRUITING · Phase 2
-
Clinical Investigation of the da Vinci Surgical System
ACTIVE NOT RECRUITING · NA
-
Post-operative Pain Control-TAP Block Using Exparel vs. Marcaine for Hernia Repairs
ACTIVE NOT RECRUITING · Early Phase 1
-
Methocarbamol in Ventral and Inguinal HR
ACTIVE NOT RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.